These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36858343)

  • 1. Deubiquitinase OTUB2 promotes intrahepatic cholangiocarcinoma progression by stabilizing the CTNNB1-ZEB1 axis.
    Wang J; Dong Y; Wei Z; Zhang Y; Wu N; Zhang C; Zhang Y; Zi R; Hao J; Liang H; Chen J
    Exp Cell Res; 2023 Apr; 425(1):113537. PubMed ID: 36858343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
    Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
    Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
    Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
    J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling.
    Lobe C; Vallette M; Arbelaiz A; Gonzalez-Sanchez E; Izquierdo L; Pellat A; Guedj N; Louis C; Paradis V; Banales JM; Coulouarn C; Housset C; Vaquero J; Fouassier L
    Hepatology; 2021 Dec; 74(6):3194-3212. PubMed ID: 34297412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OTU deubiquitinase, ubiquitin aldehyde binding 2  (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression.
    Zhu W; Wu C; Liu Z; Zhao S; Huang J
    Cell Commun Signal; 2024 Aug; 22(1):420. PubMed ID: 39210373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma.
    Jiao M; Ning S; Chen J; Chen L; Jiao M; Cui Z; Guo L; Mu W; Yang H
    Int J Oncol; 2020 Jun; 56(6):1455-1467. PubMed ID: 32236578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Gli2 stability by deubiquitinase OTUB2.
    Li XY; Mao XF; Tang XQ; Han QQ; Jiang LX; Qiu YM; Dai J; Wang YX
    Biochem Biophys Res Commun; 2018 Oct; 505(1):113-118. PubMed ID: 30241937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients.
    Tang Z; Yang Y; Zhang Q; Liang T
    Clin Epigenetics; 2023 Jan; 15(1):13. PubMed ID: 36694230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EIF3H stabilizes CCND1 to promotes intrahepatic cholangiocarcinoma progression via Wnt/β-catenin signaling.
    Wei Y; Chen W; Li Z; Xie K; Liu F
    FASEB J; 2022 Dec; 36(12):e22647. PubMed ID: 36350008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
    Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J
    PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.
    Zhang Y; Xu H; Cui G; Liang B; Chen X; Ko S; Affo S; Song X; Liao Y; Feng J; Wang P; Wang H; Xu M; Wang J; Pes GM; Ribback S; Zeng Y; Singhi A; Schwabe RF; Monga SP; Evert M; Tang L; Calvisi DF; Chen X
    Gastroenterology; 2022 Aug; 163(2):481-494. PubMed ID: 35489428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
    Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
    Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biological role of epithelial splicing regulatory protein 1 in intrahepatic cholangiocarcinoma.
    Haruna T; Kudo M; Ishino K; Ueda J; Shintani-Domoto Y; Yoshimori D; Fuji T; Kawamoto Y; Teduka K; Kitamura T; Yoshida H; Ohashi R
    Hepatol Res; 2024 Jul; ():. PubMed ID: 39037743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
    Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
    J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
    Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
    World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis.
    Yu S; Zang W; Qiu Y; Liao L; Zheng X
    Oncogene; 2022 Jan; 41(1):46-56. PubMed ID: 34671086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
    Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
    Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
    Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
    Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition.
    Yang LX; Gao Q; Shi JY; Wang ZC; Zhang Y; Gao PT; Wang XY; Shi YH; Ke AW; Shi GM; Cai JB; Liu WR; Duan M; Zhao YJ; Ji Y; Gao DM; Zhu K; Zhou J; Qiu SJ; Cao Y; Tang QQ; Fan J
    Hepatology; 2015 Dec; 62(6):1804-16. PubMed ID: 26340507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.